billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 15,580
- 荣誉分数
- 4,915
- 声望点数
- 373
Bloomberg - Are you a robot?
www.bloomberg.com
哥伦比亚大学独立研究发现
New Covid Boosters Aren’t Better Than Old Ones, Study Finds
- Results show the new shots perform similarly to past ones
- Moderna, Pfizer boosters aim to protect against new variants
Researchers at Columbia University and the University of Michigan compared levels of neutralizing antibodies in blood samples from 21 people who got a fourth shot of the Moderna or Pfizer-BioNTech SE bivalent boosters against antibody levels in 19 people who got four shots of the original vaccines.
Three to five weeks after a fourth shot, those people who received the new boosters aimed at BA.4 and BA.5 variants “had similar neutralizing antibody titers as those receiving a fourth monovalent mRNA vaccine,” the authors conclude in a manuscript posted on the preprint server bioRxiv.org. This held true for antibodies that protect against BA.4, BA.5 and older variants such as the original omicron strain, according to the study.
最后编辑: